Arch Craniofac Surg.  2021 Jun;22(3):131-134. 10.7181/acfs.2021.00185.

Treatment of Morbihan disease

• Kim JH

• KMID: 2517006
• DOI: http://doi.org/10.7181/acfs.2021.00185

Abstract

Morbihan disease (MD) is a rare condition that involves rosaceous lymphedema or erythematous lymphedema of the middle and upper thirds of the face. It typically affects the periorbital region, forehead, glabella, nose, and cheeks. The etiology of MD remains unclear, and its diagnosis is challenging. MD often tends to be unresponsive to therapies commonly used to treat rosacea, including corticosteroids, isotretinoin, and antibiotics. Surgical treatments have therefore been attempted, but most cases showed unsatisfactory responses. These problems could have resulted from an incorrect recognition and interpretation of the pathophysiology of MD and inaccurate planning of the operation, resulting in recurrence or exacerbation of edema.

Keyword

Edema; Eyelids; Lymphedema